No Data
Trump Administration Considers Lowering US Drug Prices To International Levels: Report
Roche Plans $50 Billion US Investment Over 5 Years With 12,000 New Jobs
9 Health Care Stocks With Whale Alerts In Today's Session
Concerns about the decline in U.S. stocks and the appreciation of the yen are present, but there is a sense of underlying strength.
The Nikkei average continued to decline, finishing trading at 34,220.60 yen, down 59.32 yen (Volume estimated at 1.4 billion 30 million shares). Reflecting the drop in major stock indices in the previous day's USA market, selling started ahead. There was a moment right after the opening when it turned positive at 34,340.57 yen, but the buying did not continue, and by the middle of the morning session, it had dropped to 34,109.85 yen. However, nearing the psychological barrier of 34,000 yen, there was a resistance to falling due to the bargains stemming from perceived value, and the yen exchange rate is at its highest in about seven months.
SA Asks: What's the Most Attractive Medtech Stock Right Now?
Johnson & Johnson Says TAR-200 Monotherapy Shows Highest Complete Response With Sustained Benefits In 12-month Data From Phase 2B SunRISe-1 Study (Cohort 2)